Paper101131
In vitro activity of 5-episisomicin in bacteria resistant to other aminoglycoside antibiotics.
Kabins SA and 1 other. Antimicrob Agents Chemother, 1978. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vitro activity of 5-episisomicin in bacteria resistant to other aminoglycoside antibiotics. Papers, record 101131. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/101131
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro activity of 5-episisomicin in bacteria resistant to other aminoglycoside antibiotics.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enterobacteriaceae | Major topic |
| Gentamicins | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Sisomicin | Major topic |
| Staphylococcus | Major topic |
| Drug Resistance, Microbial |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,825,406 | Gentamicin-adenylyltransferase activity as a cause of gentamicin resistance in clinical isolates of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15825406 | PubMed |
| 2 | 166,284 | Aminoglycoside-modifying enzymes. | Methods Enzymol | 1975 | https://conductscience.org/library/papers/166284 | PubMed |
| 3 | 263,886 | Infections due to gentamicin-resistant Staphylococcus aureus strain in a nursery for neonatal infants. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/263886 | PubMed |
| 4 | 626,490 | Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/626490 | PubMed |
| 5 | 825,021 | In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/825021 | PubMed |
| 6 | 868,900 | Mechanisms of resistance to aminoglycosides. | Am J Med | 1977 | https://conductscience.org/library/papers/868900 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,967,296 | 5-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6967296 | PubMed |
| 727,766 | In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/727766 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/101131
GET https://conductscience.org/api/papers/v1/101131/authors